A Comparison of Clinically Important Differences in Health‐Related Quality of Life for Patients with Chronic Lung Disease, Asthma, or Heart Disease

Abstract

These panel-derived thresholds reflect possible differences in disease management among the represented panel-specific diseases, and are all greater than the minimal CID thresholds previously developed for the SF-36 scales among patients with arthritis. If confirmed among patients with the relevant diseases and those patients' physicians, these disease-specific CIDs could assist both researchers and practicing clinicians in the use and interpretation of HRQL changes over time.